Torhild Warncke

     

    Author network for Torhild Warncke by COREMINE medical


    Publications 2018

    Namer B, Schmidt D, Eberhardt E, Maroni M, Dorfmeister E, Kleggetveit IP, Kaluza L, Meents J, Gerlach A, Lin Z, Winterpacht A, Dragicevic E, Kohl Z, Schüttler J, Kurth I, Warncke T, Jorum E, Winner B, Lampert A (2018)
    Pain relief in a neuropathy patient by lacosamide: Proof of principle of clinical translation from patient-specific iPS cell-derived nociceptors
    EBioMedicine, 39, 401-408
    DOI 10.1016/j.ebiom.2018.11.042, PubMed 30503201

    Solheim O, Skalleberg J, Warncke T, Ørstavik K, Tropé C, Fosså SD (2018)
    Long-term neurotoxicity and Raynaud's phenomenon in patients treated with cisplatin-based chemotherapy for malignant ovarian germ cell tumor
    Acta Obstet Gynecol Scand, 98 (2), 240-249
    DOI 10.1111/aogs.13477, PubMed 30289161

    Publications 2016

    Kongsgaard UE, Fischer K, Pedersen TE, Bukholm IR, Warncke T (2016)
    Complaints to the Norwegian System of Patient Injury Compensation 2001-14 following nerve blockade
    Tidsskr Nor Laegeforen, 136 (23-24), 1989-1992
    DOI 10.4045/tidsskr.16.0368, PubMed 28004547

    Publications 2014

    Schou Bredal I, Smeby NA, Ottesen S, Warncke T, Schlichting E (2014)
    Chronic pain in breast cancer survivors: comparison of psychosocial, surgical, and medical characteristics between survivors with and without pain
    J Pain Symptom Manage, 48 (5), 852-62
    DOI 10.1016/j.jpainsymman.2013.12.239, PubMed 24703940

    Publications 2013

    Jørum E, Warncke T, Ørstavik K (2013)
    [Small-fibre neuropathy]
    Tidsskr Nor Laegeforen, 133 (2), 179-83
    DOI 10.4045/tidsskr.12.0160, PubMed 23344604

    Publications 2012

    Jørum E, Warncke T (2012)
    [Treatment of chronic non-malignant pain]
    Tidsskr Nor Laegeforen, 132 (22), 2474
    DOI 10.4045/tidsskr.12.1246, PubMed 23338018

    Publications 2003

    Jørum E, Warncke T, Stubhaug A (2003)
    Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine--a double-blind, cross-over comparison with alfentanil and placebo
    Pain, 101 (3), 229-35
    DOI 10.1016/S0304-3959(02)00122-7, PubMed 12583865

    Publications 2000

    Warncke T, Stubhaug A, Jørum E (2000)
    Preinjury treatment with morphine or ketamine inhibits the development of experimentally induced secondary hyperalgesia in man
    Pain, 86 (3), 293-303
    DOI 10.1016/S0304-3959(00)00260-8, PubMed 10812259

    Publications 1997

    Warncke T, Jørum E, Stubhaug A (1997)
    Local treatment with the N-methyl-D-aspartate receptor antagonist ketamine, inhibit development of secondary hyperalgesia in man by a peripheral action
    Neurosci Lett, 227 (1), 1-4
    DOI 10.1016/S0304-3940(97)00263-2, PubMed 9178844

    Warncke T, Stubhaug A, Jørum E (1997)
    Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo
    Pain, 72 (1-2), 99-106
    DOI 10.1016/S0304-3959(97)00006-7, PubMed 9272793

    Publications 1996

    Warncke T, Brennum J, ArendtNielsen L, Branebjerg PE (1996)
    Effects of local and systemic ibuprofen on primary and secondary hyperalgesia in man
    Curr. Ther. Res.-Clin. Exp., 57 (12), 937-949

    Publications 1994

    Warncke T, Breivik H, Vainio A (1994)
    Treatment of cancer pain in Norway. A questionnaire study
    Pain, 57 (1), 109-16
    DOI 10.1016/0304-3959(94)90114-7, PubMed 8065787

    Page visits: 4060